Skip to content

Form 4 filed by Rhodes Melissa

Rhodes Melissa filed this Form 4 on AVLN (Avalyn Pharma Inc.) with 5 transaction rows and 0 holding rows, accepted by EDGAR 2026-11-19 21:05:09 UTC.

Accession
0001193125-26-468542
Filed
2026-11-19
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Issuer and reporting owners

Issuer: AVLN · Avalyn Pharma Inc. (CIK 1540171)

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
Common Stock 2026-11-17M exercised+13,300$4.6213,300D
Common Stock 2026-11-17S sold-10,875$27.79182,425D
Common Stock 2026-11-17S sold-2,025$28.2069400D
Common Stock 2026-11-17S sold-400$29.22860D
Stock Option (Right to Buy) derivative2026-11-17M exercised-13,300$0170,638D